| Alessandro Carotenuto, MD | |
|
981225 Nebraska Medical Ctr, Omaha, NE 68198-1225 | |
| (402) 559-7005 | |
| Not Available |
| Full Name | Alessandro Carotenuto |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Location | 981225 Nebraska Medical Ctr, Omaha, Nebraska |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487215919 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 8633 (Nebraska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Alessandro Carotenuto, MD 981225 Nebraska Medical Ctr, Omaha, NE 68198-1225 Ph: () - | Alessandro Carotenuto, MD 981225 Nebraska Medical Ctr, Omaha, NE 68198-1225 Ph: (402) 559-7005 |
News Archive
Depression is almost twice as common, and poor quality of life almost five times as common, in people with bipolar disorder who have elevated or low levels of the stress hormone cortisol in the blood.
In an opinion piece published Feb. 10 in the journal Science, a team of scholars led by a Johns Hopkins bioethicist urges the scientific community to act collectively to stem the negative effects of the patenting and privatizing of stem cell lines, data and pioneering technologies. This means grappling with the ambiguity of several fundamental distinctions typically made in ethics, law and common practice, the experts insist.
While our bill contains unprecedented reforms, including an end to discrimination for pre-existing conditions and a prohibition on raising rates or dropping coverage if you become ill, our bill cannot include provisions some strongly advocated. The single payer alternative is one of those provisions that could not be included in H.R. 3962, but which has generated support within the Congress and throughout the country.
YM BioSciences Inc. has announced data from two clinical trials of nimotuzumab, its humanized monoclonal antibody that targets the epidermal growth factor receptor (EGFR). Preliminary results from the two trials which are evaluating nimotuzumab in combination with radiation therapy for the treatment of brain metastases and high-grade gliomas, conducted by YM's licensor, were presented at the 2008 EORTC-NCI-AACR annual meeting recently held in Geneva, Switzerland.
Insulin-sensitizing drugs can help thin women with polycystic ovary syndrome even if they do not appear to be insulin resistant, broadening the range of women who can benefit from the therapy, a Virginia Commonwealth University researcher said in this month's issue of the journal Fertility and Sterility.
› Verified 6 days ago
Rahul Mahendra Varman, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 7710 Mercy Rd Ste 3000, Omaha, NE 68124 Phone: 402-932-1999 | |
Tyler Andrew Bliss, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 981225 Nebraska Medical Ctr, Omaha, NE 68198 Phone: 316-208-9184 | |
Debora Goebel, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 720 N 129th St, Omaha, NE 68154 Phone: 402-397-0670 Fax: 402-397-0713 | |
Justin Oltman, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 981225 Nebraska Medical Ctr, Omaha, NE 68198 Phone: 402-559-7005 Fax: 402-559-8940 | |
Anne Kristin Maxwell, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 4014 Leavenworth St, Ent Clinic At Laurizten Outpatient Center, Omaha, NE 68105 Phone: 402-559-5208 | |
John W Pflug, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 16929 Frances St, Suite 201 Omaha Ear, Nose & Throat Clinic, Omaha, NE 68130 Phone: 402-758-5330 Fax: 402-758-5339 | |
James V Huerter Jr., MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 17030 Lakeside Hills Plz, Suite 204, Omaha, NE 68130 Phone: 402-758-5600 Fax: 402-758-5169 |